Janux Therapeutics, Inc. (JANX) vs MeiraGTx Holdings plc (MGTX)
A side-by-side comparison of Janux Therapeutics, Inc. and MeiraGTx Holdings plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
JANX
Janux Therapeutics, Inc.
$16.37HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
MGTX
MeiraGTx Holdings plc
$10.64HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
Total return — JANX vs MGTX
growth of $100 · dividends reinvested · last 5yJANX -34.2% (-8.0%/yr)MGTX -26.6% (-6.0%/yr)MGTX compounded faster over this window
JANX MGTX
JANX vs MGTX: by the numbers
- •JANX is the larger company ($998M vs $985M market cap).
- •MGTX is profitable (19.87% net margin) while JANX runs a net loss (-321.81%).
- •JANX grew revenue faster over the past five years (105.89% vs 84.52% CAGR).
Metrics side by side
Valuation
| Metric | JANX | MGTX |
|---|---|---|
| P/E ratio | N/A | 14.99 |
| Forward P/E | N/A | 35.47 |
| P/S ratio | 31.32 | 2.48 |
| P/B ratio | 1.08 | 4.57 |
| EV / EBITDA | N/A | 4.86 |
Profitability
| Metric | JANX | MGTX |
|---|---|---|
| Gross margin | 79.71% | 97.19% |
| Operating margin | -1576.67% | -130.20% |
| Net margin | -321.81% | 19.87% |
| ROE | -11.06% | 36.64% |
| ROIC | -15.15% | 52.81% |
Growth (annualized)
| Metric | JANX | MGTX |
|---|---|---|
| Revenue CAGR (5Y) | 105.89% | 84.52% |
| Total return CAGR (5Y) | -6.45% | -3.10% |
Some values include inputs from SEC filing.
Frequently asked
- Which has grown faster, JANX or MGTX?
- Over the past five years, JANX grew revenue faster — JANX at a 105.89% CAGR versus MGTX at 84.52%.
- Is JANX or MGTX more profitable?
- MGTX runs the higher net margin — JANX at -321.81% versus MGTX at 19.87%.
- How have JANX and MGTX total returns compared?
- Over the past 5 years, JANX delivered -6.45% and MGTX delivered -3.10% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
MeiraGTx P/E ratioJanux Therapeutics ROEMeiraGTx ROEJanux Therapeutics operating marginMeiraGTx operating marginJanux Therapeutics revenue growthMeiraGTx revenue growthJanux Therapeutics free cash flowMeiraGTx free cash flow
Janux Therapeutics & MeiraGTx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.